the skin, decreased skin temperature and moderate rigor of the muscles. Although early diagnosis and treatment is important, the time factor does not contraindicate the surgical treatment itself. When ischemia becomes irreversible, there is blotchy cyanotic discolouration not influenced by digital pressure, the calf muscle has a firm consistency and there is anesthesia and paralysis of the extremity. 2 Very little published epidemiological data are available to establish the real incidence of APAO in the general population. An audit carried out in Gloucestershine have found a 14/100,000 incidence of acute limb ischemia (ALI) in the general population, which increases to 17 per 100,000 if bypass graft occlusions were included. 8 The Swedish Vascular Registry confirms the data, reporting 13/100,000 regional incidence. 9 A few study of management of peripheral limb ischemia were done previously in Bangladesh. They were limited on outcome of treatment of peripheral limb ischemia irrespective of the time of intervention. This comparative study evaluated the outcome of early surgical intervention in lower limb ischemia due to thromboembolism.
Methods and Materials:
The present study evaluated the outcome of early and late surgical intervention in acute lower limb ischemia due to thromboembolism. It was a non randomized comparative parallel study conducted in the Department of Cardiovascular Surgery, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh between the periods January 2007 and December 2008.
Patients who were scheduled for surgical revascularization for ALI due to thromboembolism were enrolled in the study. Convenient non-probability sampling technique was applied in the study. Total number of patients was 80. The patients were divided into equal two groups. Group A (n=40) for early surgical intervention (within 24 hours) and Group B (n=40) for late surgical intervention (more than 24 hours). Patient with chronic lower limb ischemia, patient with major tissue loss or permanent nerve damage, patient with prosthetic graft, patients with gangrenous limb, patients with known pre-existing peripheral vascular disease and re-operation were excluded from the study. Doppler studies were done in every patient before and after operation for diagnosis and to evaluate post operative out come. All data were analyzed by using computer based SPSS (statistical programme for social science). Data were expressed in frequency, percentage, mean ± SD as applicable. Comparison between the groups was done by Chi-squared test and Student t test as applicable. p value of less than 0.05 was considered as significant.
Results:
In the present study Mean (±SD) age of Group A and Group B were 51.93 (± 11.73) and 47.00 (± 11.01) years respectively. In Group A maximum 30.0% belonged to 45 to 55 years age range followed by 25.0% within 55-65 years, 20.0% were within 35 to 45 years, 15% above 65 years and 10.0% up to 35 years age range. In Group B maximum 42.5% belonged to 35 to 45 years age group followed by 32.5% within 45 to 55 years, 10.0% above 65 years, 7.5% up to 35 years and 7.5% 55-65 years age group. Male and female in Group A and in Group B were 67.5% and 32.5% and 60.0% and 40.0% respectively.
Regarding occupation in Group A, service holder, housewife, businessman, retired and other professionals were 12.5%, 32.5%, 30.0%, 15.0%, and 10.0% respectively and in Group B they were 25.0% maximum 37.5%, 7.5% 10.0% and 20.0% respectively. Smoker in Group A and Group B were 62.5% and 50.0% respectively. In Group A and Group B there were 42.5% and 27.5% had diabetes mellitus respectively. In group A 55.0% were hypertensive and in group B 40.0% were hypertensive (Table I ). All patients of group A and group B had history of pain and absence of pulse distal to occlusion. 92.5% patients of group A had cold and 7.5% had warm extremity, on the other side in group B 97.5% had cold and 2.5% had warm extremity. Intact sensory function in Group A and Group B were 12.5% and 7.5% respectively and intact motor function were 20.0% and 10.0% respectively. (Table III) . 
Discussion:
Acute lower extremity ischemia continues to be associated with significant limb loss and mortality despite advances in endovascularbased therapies and overall improved critical care. 1 In the present study total 80 patients with acute lower limb ischemia were enrolled and they were divided into equal two groups, Group A for early surgical intervention (within 24 hours) and Group B for late (more than 24 hours). The aim of this study was to evaluate the outcome of surgical intervention in acute lower limb ischemia due to thromboembolism. In the present study the mean (±SD) of age in Group A and Group B were 51.93 (± 11.73) and 47.00 (± 11.01) years respectively. In the present study in Group A 67.5% were male and 32.5% were female and in Group B 60.0% were male and 40.0% were female. Male and female ratio was 1.76:1. Antusevas and Aleksynas, 10 in a study of 74 men with acute ischemia in the lower limb found that mean±SD of age was 68.3±12 years, and for 68 women that was76.2±8years. In Mutirangura et al. 11 series mean (±SD) age of early acute and late acute group was 61.0±17.0 and 61.6±17.0 years respectively which was inconsistent with our result. Iyem and Eren, 12 in a study of the 122 patients showed that mean±SD of age was 54.2 ± 16.8 years. In their study 71 were male and 51 were female. In Mutiranrura et al. 11 series in early acute group male and female was 48.4% and 51.6% and in late acute group 70.0% and 30.0% respectively and male and female ratio in their study was 1.67:1, which is consistent with our result.
In Group A 62.5% were smoker and in Group B 50.0%. In group A and group B 7.5% from each group had history of taking alcohol. Diabetes mellitus present in 42.5% and 27.5% in Group A and Group B respectively. In group A 55.0% had HTN and in group B 40.0% had Hypertension. Atrial fibrillation, Aortic stenosis and stroke observed in both group A and group B and were 45.0% and 60.0%, 15.0% and 7.5% and 5.0% and 5.0% respectively. In the present study there is no statistically significant difference in age, sex, occupation, smoking habit and medical condition between the groups. In Mutiranrura et al. 11 series 48.4% of early acute group and 56.7% of late acute group were smoker and 27.5% patients were hypertensive and 27.5% were diabetic.
Acute ischemic pain (93.4%) was the most common clinical manifestation of acute arterial embolism of their series followed by pallor (94.5%), sensory loss (86.8%), and paralysis (74.7%). Muscle weakness was more In Group A 57.5% had superficial femoral artery occlusion followed by 22.5% iliac artery and 20.0% popliteal artery occlusion. In Group B 42.5% had superficial femoral artery occlusion, 32.5% had popliteal artery occlusion and 25.0% had iliac artery occlusion. Antusevas and Aleksynas, 10 in a study showed that thrombosis damaged the femoral artery for 37.9%, iliac artery for 22.7%, popliteal artery for 22.2% patients and embolism was in the femoral artery for 32.9 %, popliteal artery for 4.7%, and tibialis artery for 7% patients.
In Group A, 27.5% had viable muscle, 67.5% had borderline and 5.0% had no viability and in Group B 22.5% had viable muscle, 67.5% had borderline and 10.0% had dead muscle (p>0.05 16 that included 24 patients, the amputation rate was reported as 29.2% and the mortality rate as 29.2%. In another study by Karapolat et al. 17 the amputation rate of arterial embolectomy beyond 24 hours was reported to be 11.4%. Iyem and Eren, 12 in a study showed that 11.47% had fasciotomy and 7.37% had amputation. Becquemin and Kovarsky, 18 and Pellegrino, 19 in their study found that the major amputation rate in thrombosis and embolism cases were 16.0% and 11.0%. Illuminati et al. 20 in their study found that the major amputation rate in thrombosis and embolism cases were 37.7% and 17.2% and Kuukasjarvi and Salenius, 21 in their study found that the major amputation rate in thrombosis and embolism cases were 26.0% and 10.0%.
Due to the toxic metabolic product accumulated in and released by the more than 24-hour ischemic tissue, alteration of the systemic haemodynamics leading to multiple organ dysfunction and major amputation was not uncommon of major limb loss before and after revascularization and the less successful outcomes of treatments were observed in those patients with more than 24-hour duration.
Complete revascularization rate was observed in both group of our study was 80.0% and 65.0% respectively (p>0.05). The successful revascularization after the initial embolectomy was similar in Mutiranrura et al. 11 series in the management of early acute embolism than that of late acute embolism (83.9% vs. 58.3%, p < 0.001). These were the consequence of the adhesiveness between the emboli and the endothelium of the occluded arterial segment where the duration occlusion lasted more than 24 hours. Therefore, the complete removal of those emboli could not be simply accomplished by surgical embolectomy alone. Despite the deployment of varying modalities of primary treatment, major amputation after revascularization in patients with late acute embolism superseded those with early acute embolism (24.4% vs. 7.4%, p < 0.106). Total death rate was reported 5.0% and 10.0% for Group A and Group B respectively. Almost similar result (9.7% vs. 15.0%) was observed by Mutiranrura et al. 11 . Taviloglu et al. 22 showed that mortality rates have reported as 12.5% within 12 hours and 37.7% thereafter.
Conclusion:
Duration of embolism may be the significant factor determining the outcomes of the management of acute arterial embolism in the lower extremities. The higher tendency of developing extensive limb gangrene, the higher number of major limb loss before and after revascularization and the less successful outcomes of treatments were observed in those patients with more than 24-hour duration.
Recommendation:
Duration of arterial embolism is a crucial factor influencing the surgical management of acute lower limb ischaemia due to thromboembolism. So, early diagnosis and shifting of patients to specified centre as early as possible to save limb as well as life.
